Over the years, Glaucoma 360 has brought the concept of innovation in glaucoma to the forefront. This year’s meeting will surpass the Glaucoma Research Foundation’s (GRF) own “Horizons” by adding a few more “degrees” to its 360-degree concept.
Glaucoma 360 is an all-encompassing event where clinicians, researchers, members of the ophthalmic industry, and philanthropy converge on San Francisco for fund-raising activities, education, and awareness to achieve one goal––finding a cure for glaucoma. The event began Thursday night (Feb. 2) with the Glaucoma 360 annual Gala and runs through Saturday (Feb. 4) at the Palace Hotel.
Ophthalmology Times is “The Official Partner and Media Sponsor” for the meeting.
Adrienne Graves, PhD, and Andrew Iwach, MD, both of whom serve on GRF’s Board of Directors, founded the Glaucoma 360 meeting 6 years ago and serve as its co-chairpersons.
“What GRF is most excited about is the amount of innovation and change in the field of glaucoma since we started Glaucoma 360,” Dr. Graves said. “It reinforces the importance of GRF and a meeting like Glaucoma 360, highlighting new technologies and bringing together all of the parties that are needed to develop new technologies successfully.”
The 2017 Glaucoma 360 meeting expands the program to include clinical topics on dry eye and telemedicine. The biggest expansion, however, is the second annual Optometric Glaucoma Symposium, planned for Saturday afternoon.
Dr. Iwach initiated the program for optometrists last year with a soft rollout to make sure GRF had the right formula. He was sure optometrists would be receptive to the concept. The program was well-received with 150 attendees.
This year, GRF has made a push to build the program with a mixture of topics and a diverse faculty. Almost 400 optometrists are expected to attend.
“Ultimately, it’s the same basic principles (of Glaucoma 360),” Dr. Iwach said. “We want to leave practical considerations and points with the attendees. We took the information we learned from last year’s meeting and tried to make it better.”
Dr. Graves added that optometrists play a pivotal role in treating glaucoma patients.
“It was very important to expand the universe that (GRF) is exposing to new technologies,” she added. “Optometrists have been very responsive and are very excited to have a program that addresses their needs.”